Navigation Links
MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference
Date:2/2/2009

VALENCIA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference on Monday, February 9, 2009 at 2:15 PM (EST) at the Hilton Waldorf Astoria in New York City. In addition to this presentation, the Company will host a breakfast meeting for invited investors and analysts at 7:30 AM (EST) on February 10th.

Interested parties can access links to live webcasts of both presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com. Replays of the presentations will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA, which has completed Phase 3 clinical trials, and MKC253, which is currently in Phase 1 clinical trials. Both of these investigational products are being evaluated for their safety and efficacy in the treatment of diabetes. MannKind maintains a website at https://www.mannkindcorp.com to which MannKind regularly posts copies of its press release as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to email alerts that are sent automatically when MannKind issues press releases, files its reports with the SEC or posts certain other information to the website.


'/>"/>
SOURCE MannKind Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
2. MannKind to Present at the Piper Jaffray 20th Annual Health Care Conference
3. MannKind to Present at the Rodman & Renshaw Annual Global Investment Conference
4. MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
5. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
6. MannKind to Present at the UBS Global Life Sciences Conference
7. MannKind Corporation Reports Second Quarter Financial Results
8. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
9. MannKind to Present at Upcoming Conferences
10. MannKind Corporation Reports First Quarter Financial Results
11. MannKind to Present at the Morgan Stanley Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Freeslate, Inc ., the ... that Lupin Limited, one of India’s top five pharmaceutical ... PharmD System for high throughput solid form screening. ... on a wide range of quality, affordable generic and ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Computers might one day recycle part of their own waste ... State University. The material is a semiconductor called gallium ... Materials , researchers describe the detection of an effect that ... spin in a semiconductor. Once developed, the effect ...
... 2010 ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
... Call to Discuss Results for Fourth Quarter Fiscal 2010 -- LAIYANG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
Cached Biology Technology:Semiconductor could turn heat into computing power 2Semiconductor could turn heat into computing power 3Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 2Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 3Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 4Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 5Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 6Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 7Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 8Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 9Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 2Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 3Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 4Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 5Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 6Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 7
(Date:4/24/2014)... or a stop sign? Or have you heard someone ... totally missed seeing? , "When we have different things ... of so much of what we see," said Kyle ... Illinois. "For example, when you,re driving, you might really ... there,s an unexpected event: an emergency vehicle, a pedestrian, ...
(Date:4/24/2014)... COLUMBIA, Mo. When bacteria attack plants, they ... cells to weaken and suppress natural defenses. However, ... the plant cells as a potential host. Now, ... and replicated the process that allows the bacteriaknown ... discovery could lead to natural anti-infective treatments that ...
(Date:4/24/2014)... New research led by Alison Allan, PhD, a scientist ... shows why breast cancer often spreads or metastasizes to ... diagnosed cancer and the number two cause of cancer-related ... early, traditional chemotherapy and radiation have a high success ... many conventional treatments fail. In particular, the lung is ...
Breaking Biology News(10 mins):Controlling brain waves to improve vision 2Controlling brain waves to improve vision 3Plants send out signals attracting harmful bacteria, MU study finds 2New study helps to explain why breast cancer often spreads to the lung 2
... a significant step forward in understanding the causes of some forms ... 7 motor protein - found in the tiny hairs of the ... a different way from many other myosins. , Dr ... says: "We,re really excited by this discovery as it could lead ...
... Oncology (ESMO), the European Society for Therapeutic Radiology ... Surgeons (ESTS) and the European Respiratory Society (ERS) ... Conference on Thoracic Oncology (EMCTO). This meeting ... perspective of state-of-the-art on the prevention, screening, ...
... SPRING HARBOR, N.Y. (Tues., March 3, 2009) ... proteins in cells are featured in the March issue ... ). Thomas J. Wandless and colleagues from Stanford ... Protein Stability in Mammalian Cells Using Small Molecules." This ...
Cached Biology News:Study offers clues to beating hearing loss 2European Multidisciplinary Conference on Thoracic Oncology 2European Multidisciplinary Conference on Thoracic Oncology 3Protein function and chromatin structure methods featured in Cold Spring Harbor Protocols 2
Rabbit Anti-JNK1/SAPK pan, Polyclonal Antibody...
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Biology Products: